(Q35809851)

10 August 2017

Surface antigen expression and complement susceptibility of differentiated neuroblastoma clones (English)

1 reference

10 August 2017

1 reference

S Chen

1

1 reference

10 August 2017

T Caragine

series ordinal

2

1 reference

10 August 2017

N K Cheung

series ordinal

3

1 reference

10 August 2017

S Tomlinson

series ordinal

4

1 reference

10 August 2017

language of work or name

English

0 references

publication date

1 March 2000

1 reference

The American Journal of Pathology

10 August 2017

1 reference

10 August 2017

156

1 reference

10 August 2017

3

1 reference

10 August 2017

1085-1091

1 reference

Mapping the active site of CD59

10 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1876851

Complement activation on human neuroblastoma cell lines in vitro: route of activation and expression of functional complement regulatory proteins.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1876851

Monoclonal antibodies to a glycolipid antigen on human neuroblastoma cells.

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1876851

Phenotypic diversification in human neuroblastoma cells: expression of distinct neural crest lineages

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1876851

Decay-accelerating factor protects human tumor cells from complement-mediated cytotoxicity in vitro

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1876851

Distribution of decay-accelerating factor in the peripheral blood of normal individuals and patients with paroxysmal nocturnal hemoglobinuria

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1876851

Complement-mediated tumor cell damage induced by antibodies against membrane cofactor protein (MCP, CD46).

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1876851

Quantitative analysis of membrane cofactor protein (MCP) of complement. High expression of MCP on human leukemia cell lines, which is down-regulated during cell differentiation

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1876851

Mapping of epitopes, glycosylation sites, and complement regulatory domains in human decay accelerating factor

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1876851

Expression and function of the complement membrane attack complex inhibitor protectin (CD59) on human breast cancer cells

27 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1876851

Coordinate morphological and biochemical interconversion of human neuroblastoma cells.

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1876851

CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells

25 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1876851

Lysis of human tumor cell lines by canine complement plus monoclonal antiganglioside antibodies or natural canine xenoantibodies

25 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964976-0

Expression of rat CD59: functional analysis confirms lack of species selectivity and reveals that glycosylation is not required for function

7 January 2021

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964976-0

Anti-G(D2) antibody treatment of minimal residual stage 4 neuroblastoma diagnosed at more than 1 year of age

7 January 2021

1 reference

Crossref

https://api.crossref.org/works/10.1016%2FS0002-9440%2810%2964976-0

Transdifferentiation of human neuroblastoma cells results in coordinate loss of neuronal and malignant properties

7 January 2021

1 reference

12 December 2020

Human protectin (CD59), an 18,000-20,000 MW complement lysis restricting factor, inhibits C5b-8 catalysed insertion of C9 into lipid bilayers

1 reference

12 December 2020

Cell lineage and differentiation state are primary determinants of MYCN gene expression and malignant potential in human neuroblastoma cells

1 reference

12 December 2020

3F8 monoclonal antibody treatment of patients with stage 4 neuroblastoma: a phase II study

1 reference

12 December 2020

10.1016/S0002-9440(10)64976-0

Identifiers

DOI

1 reference

10 August 2017

1 reference

10 August 2017

PubMed publication ID

10702424

1 reference